relationship between changes in serum cytokine levels after artificial liver therapy and clinical prognosis in patients with liver failure

Clicks: 126
ID: 176075
2013
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #66 of 78 articles by views in lontar komputer

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
ObjectiveTo investigate the relationship between changes in serum cytokine levels at 72 h after artificial liver therapy (plasma exchange, PE) and clinical prognosis in patients with liver failure. MethodsFifty-eight patients with liver failure, who received PE in Department of Infectious Diseases, The No. 2 People′s Hospital of Lanzhou from April 2011 to April 2012, were included in the investigation; they were divided into improved group and uncured group according to their treatment outcomes. The serum interleukin (IL)-4, IL-6, IL-10, tumor necrosis factor (TNF)α, and interferon (IFN)γ levels before and 72 h after therapy were measured, and the relationship between the changes in these indices and prognosis was observed. The data were expressed in the form of mean ± standard deviation. The baseline values and values after therapy were compared by paired t-test, and the differences between two groups were determined by the t-test for comparison between groups. ResultsAfter PE therapy, 67.24% of all patients (39/58) showed an improvement, while 32.75% (19/58) were not cured. At 72 h after therapy, the improved group had significant changes in serum IL-4, IL-6, IL-10, TNFα, and IFNγ levels (t=2.048-5.163, P<0.05), and had more decrease in serum IL-4, IL-6, TNFα, and IFNγ and more increase in serum IL-10 level compared with the uncured group. Before therapy, the serum IL-6 and TNFα levels were significantly higher in the uncured group than in the improved group (t=2.024-2.174, P<0.05). ConclusionArtificial liver therapy can decrease TNFα, IL-4, IL-6, and IFNγ and increase IL-10 in serum and thus is an effective treatment for liver failure. It seems that IL-6 and TNFα play a more important role than other cytokines in immune injury in patients with liver failure.
Reference Key
jian2013linchuangrelationship Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;ZHOU Jian
Journal lontar komputer
Year 2013
DOI
10.3969/j.issn.1001-5256.2013.07.015
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.